Spinal Elements Expands Ventana® Platform with FDA 510(k) Clearance and First Cases of Ventana® A ALIF System

CARLSBAD, Calif., March 18, 2026 /PRNewswire/ -- Spinal Elements®, a spine technology company known for developing innovative surgical solutions that prioritize clinical performance and surgical efficiency, today announced 510(k) clearance from the FDA and the first cases using its Ventana A Anterior Lumbar Interbody Fusion (ALIF) System. Ventana A strengthens Spinal Elements' family of 3D printed titanium interbodies for lumbar and cervical fusion and is being introduced through a limited market launch.

Ventana A is designed to facilitate the race to fusion and deliver improved outcomes for surgeons and patients. The unique hinged architecture of the Ventana family of implants is designed to maximize bone graft volume and containment throughout implantation. Through a specialized 3D printing process, Ventana A is engineered to enable surgeons to realize the full potential of the ALIF procedure, by restoring segmental alignment and stability, minimized titanium density, providing optimal load sharing to mitigate potential subsidence risk and improved visualization.

“ALIF is a powerful procedure and a workhorse for many spine surgeons, which is why we set out to develop a best-in-class system that maximizes its clinical benefits,” said Ron Lloyd, Chief Executive Officer. “Building on the proven Ventana platform, this contemporary system increases Spinal Elements’ portfolio offering and procedural reach to a greater number of surgeon and distribution partners. Combined with intuitive instrumentation and efficient packaging, Ventana A is designed to enhance clinical performance and operating room efficiency, demonstrating our commitment to continued innovation – working with surgeon partners to develop systems that are meaningfully differentiated and deliver improved outcomes”.

Sign up for Blog Updates